SlideShare a Scribd company logo
Avant, RN
About Holy Family Hospital
• Established in 1954 by the Medical Missions Sisters
• Has grown and developed to become the Municipal Hospital for the Techiman
Municipality
Serves as the referral health facility for the Municipality and beyond
• Vision - to become a teaching hospital of medical excellence and leading Christ-
centered healthcare provider in the country.
• Mission - to provide quality healthcare in the most effective, efficient and
innovative manner, specific to the needs of the communities it serve and at all
times acknowledge the dignity of the patients.
• Goal - to provide and sustain good quality health care for all manner of
persons and empower them to take ownership of their own individual and
collective health needs.
Services/units
• General services
Internal medicine
Outpatient department
Accident and emergency
• Specialist services
Surgery
Mental health
Ear, Nose & Throat
Dental
Physiotherapy
Obstetrics & Gynaecology
• Diagnostics
Laboratory services
Endoscopy
Radiology
Laparascopy
Collaborators/Partners
German Rotary volunteer Doctors (GRVD) since 2011.
• The main objectives of the collaboration are to build capacity to improve specialist
services to the rural population.
Operation International, an NGO in New York - USA, and the UK
since 2013.
• HFH has been identified and used as a site for medical and surgical
Radboud University - Nijmegen, the Netherlands.
CHAG
Goals
• To gain valuable industry knowledge and experience – nurses unique
role is to promote quality health care and improve clinical outcomes, yet
ensuring minimal cost of care.
• To develop interpersonal skills – nurses may spend much of their time
interacting with patients in sensitive circumstances, such as illness and
grief.
• To become a better patient advocate – nurses are constantly mediating
conversations between patients and physicians about treatment plans,
helping patients understand medical condition and treatment regimen.
• To improve technological skills – it is imperative to stay current on newer
technological advancements in the health care sector and to integrate
them into practice.
• To build professional network – as nurses progress in their career and
Interests
• Directly caring for patients – the joy you put on their face, the smile they
wear…
• Volunteering, community service or charity work
• Cooking
• Sightseeing
• Singing
• Reading
Devices operated
Medical conditions
• Hypertension
• Diabetes
• Cerebrovascular accident – CVA
• Heart disease
• Meningitis
• Pneumonia
• RTI
• Nifedipine – calcium channel blocker, MoA unknown, but may inhibit
Ca+ influx across cardiac and smooth muscles, decreasing myocardial
contractility and oxygen demand. 10-20mg tid for Angina Pectoris, 30-
60mg dly adjusted over 7-14days for hypertention
• Hydralazine – vasodilator, MoA unknown, but in response to
arteriolar dilation, peripheral resistance and blood pressure falls, HR
and myocardial contractility increases 10mg qid up tp 50mg
• Lisinopril –ace inhibitor, MoA unknown may result primarily from
suppression of the RAAS system, 10mg, effective dosage 20-40mg dly
• Isosorbide – antianginal drug , reduces cardiac oxygen demand by
decreasing left ventricular end diastolic pressure (preload) 2.5 -2.6
Hypertension
Also known as high blood pressure (HBP), is a long term medical condition in which the blood pressure in the
arteries is persistently elevated, (SBP ≥140 mmHg and DBP ≥90 mmHg).
Pre hypertension: SBP: 120-139 mmHg, DBP: 80-89 mmHg
Hypertension stage I: SBP: 140-159 mmHg, DBP: 90-99 mmHg
Hypertension stage II: SBP: More or equal to 160 mmHg, DBP: More or equal to 100 mmHg
Pregnancy induced HTN: because of increased production of hormones and enzymes during pregnancy.
Medical management
 Diuretics: it helps the kidneys to inhibit the sodium reabsorption in the distal convoluted tubules, ascending limb and loop of Henle (E.g.: chlorothiazide -
0.5 -1g, furosemide - starting dose is 80 mg per day, taken as 40 mg twice each day)
Beta blockers: These medications reduces the workload of the heart and blood vessel and causing the heart to beat slowly
and with less force (E.g.: Atenolol - 25mg to 50mg, propranolol - 40 mg orally 2 times a day)
Alpha blockers: These medications causes the peripheral vasodilation of blood vessels (E.g.: Prazosin - 1 mg orally 2 or
3 times a day)
Vasodilators: These medications acting directly on the muscles in the wall of arteries and preventing the muscles from
tightening and arteries from narrowing. (E.g.: Nitro-glycerine - 5 mcg/min continuous IV infusion increase 3 – 5min up to 20),
Sodium nitro prusside)
ACE Inhibitors: This group of medication will reduce the conversion of A-I to A-II and prevents vasoconstriction (Eg:
Captopril - 25 mg orally 2 to 3 times a day one hour before meals, Ramipril)
Calcium channel blockers: These medicines will block the movement of extra cellular calcium into the cells and causing
vasodilation and decreased heart rate (E.g.: Amlodipine - 5 to 10 mg/day, Verapamil)
Antidiabetes
• Sulfunalurease - stimulate insulin secretion from the beta cells of the pancreas, thus increasing
insulin levels. Improve sensitivity to insulin in tissues, lower blood glucose levels
• 1st Generation - Chlorpropamide, tolbutamide, tolazamide
• 2nd Generation – glimepiride, glipizide, glyburide
• Meglitinides – repaglinide similar to sulfunalurease
• Biguanides – metformin, Decrease production of glucose, Increase uptake of glucose by
tissues
• Thiazolidinediones, eg. Actos, Avandia - Decrease insulin resistance
• Alpha-glucosidase inhibitors, e.g. acarbose reversibly inhibit the alpha-glucosidase in the small
intestine, delayed absorption of glucose
• Insulin - Restores the diabetic patient’s ability to:
• Metabolize carbohydrates, fats, and proteins
• Store glucose in the liver
• Convert glycogen to fat stores
Antimalarial
• Artesunate
• Artemether
• Lumefantrine - Against erythrocytic (but not other) stages of all four
malaria species. MOA: unknown.
• Chloroquine - Acts by :concentrating in parasite food vacuoles, preventing
the biocrystallization of the hemoglobin breakdown product
• Amodiaquine

More Related Content

Similar to Avant, RN Interview.pptx

Periodontal treatment of medically compromised patient
Periodontal treatment of medically compromised patientPeriodontal treatment of medically compromised patient
Periodontal treatment of medically compromised patient
Dr Saif khan
 
Congestive Heart Failure- Part II
Congestive Heart Failure- Part IICongestive Heart Failure- Part II
Congestive Heart Failure- Part II
Ankita Bist
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
Ranjit Saha
 
Approach to hypertensive emergencies in children
Approach to hypertensive emergencies in childrenApproach to hypertensive emergencies in children
Approach to hypertensive emergencies in children
AshwiniBelur2
 
Dialysis
DialysisDialysis
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
Dr Ketan Asawalle
 
Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
Kanchan Devi
 
Management of hypertension (final)
Management of hypertension (final)Management of hypertension (final)
Management of hypertension (final)
IJAZ HUSSAIN
 
Hypertension
HypertensionHypertension
Hypertension
Oriba Dan Langoya
 
Hypertension (1).ppt
Hypertension (1).pptHypertension (1).ppt
Hypertension (1).ppt
NajmKhan6
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
O. E.Nyandi PhD
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guide
meducationdotnet
 
No Title
No TitleNo Title
11241869.ppt
11241869.ppt11241869.ppt
11241869.ppt
ssuser497f37
 
Hypertension - Nursing Practise
Hypertension - Nursing PractiseHypertension - Nursing Practise
Hypertension - Nursing Practise
Mónica Roque
 
Heart System Disease
Heart System Disease Heart System Disease
Heart System Disease
DR .PALLAVI PATHANIA
 
REXTO PEDIATRICS MANAGEMENT OF HEART FAILURE (1).docx
REXTO  PEDIATRICS MANAGEMENT OF HEART FAILURE  (1).docxREXTO  PEDIATRICS MANAGEMENT OF HEART FAILURE  (1).docx
REXTO PEDIATRICS MANAGEMENT OF HEART FAILURE (1).docx
Rexto
 
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
DrHafashimanaEmmanue
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
O. E.Nyandi PhD
 
HYPERTENSION/high blood pressure- a lecture-1.pptx
HYPERTENSION/high blood pressure- a lecture-1.pptxHYPERTENSION/high blood pressure- a lecture-1.pptx
HYPERTENSION/high blood pressure- a lecture-1.pptx
EmmanuelIshioma
 

Similar to Avant, RN Interview.pptx (20)

Periodontal treatment of medically compromised patient
Periodontal treatment of medically compromised patientPeriodontal treatment of medically compromised patient
Periodontal treatment of medically compromised patient
 
Congestive Heart Failure- Part II
Congestive Heart Failure- Part IICongestive Heart Failure- Part II
Congestive Heart Failure- Part II
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Approach to hypertensive emergencies in children
Approach to hypertensive emergencies in childrenApproach to hypertensive emergencies in children
Approach to hypertensive emergencies in children
 
Dialysis
DialysisDialysis
Dialysis
 
Recent Advances in CCF
Recent Advances in CCFRecent Advances in CCF
Recent Advances in CCF
 
Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
 
Management of hypertension (final)
Management of hypertension (final)Management of hypertension (final)
Management of hypertension (final)
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension (1).ppt
Hypertension (1).pptHypertension (1).ppt
Hypertension (1).ppt
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
 
Phamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision GuidePhamacological Management of Essential Hypertension - Revision Guide
Phamacological Management of Essential Hypertension - Revision Guide
 
No Title
No TitleNo Title
No Title
 
11241869.ppt
11241869.ppt11241869.ppt
11241869.ppt
 
Hypertension - Nursing Practise
Hypertension - Nursing PractiseHypertension - Nursing Practise
Hypertension - Nursing Practise
 
Heart System Disease
Heart System Disease Heart System Disease
Heart System Disease
 
REXTO PEDIATRICS MANAGEMENT OF HEART FAILURE (1).docx
REXTO  PEDIATRICS MANAGEMENT OF HEART FAILURE  (1).docxREXTO  PEDIATRICS MANAGEMENT OF HEART FAILURE  (1).docx
REXTO PEDIATRICS MANAGEMENT OF HEART FAILURE (1).docx
 
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
8. MANAGEMENT OF HYPERTENSIVES DISEASES IN PREGNANCY Dr Phillip Nov 2023 - Co...
 
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
Management of Hypertension in Diabetic Patients with Chronic Kidney Disease: ...
 
HYPERTENSION/high blood pressure- a lecture-1.pptx
HYPERTENSION/high blood pressure- a lecture-1.pptxHYPERTENSION/high blood pressure- a lecture-1.pptx
HYPERTENSION/high blood pressure- a lecture-1.pptx
 

Recently uploaded

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 

Recently uploaded (20)

CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdfHiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital Powai News [Read Now].pdf
 

Avant, RN Interview.pptx

  • 2. About Holy Family Hospital • Established in 1954 by the Medical Missions Sisters • Has grown and developed to become the Municipal Hospital for the Techiman Municipality Serves as the referral health facility for the Municipality and beyond • Vision - to become a teaching hospital of medical excellence and leading Christ- centered healthcare provider in the country. • Mission - to provide quality healthcare in the most effective, efficient and innovative manner, specific to the needs of the communities it serve and at all times acknowledge the dignity of the patients. • Goal - to provide and sustain good quality health care for all manner of persons and empower them to take ownership of their own individual and collective health needs.
  • 3. Services/units • General services Internal medicine Outpatient department Accident and emergency • Specialist services Surgery Mental health Ear, Nose & Throat Dental Physiotherapy Obstetrics & Gynaecology • Diagnostics Laboratory services Endoscopy Radiology Laparascopy
  • 4. Collaborators/Partners German Rotary volunteer Doctors (GRVD) since 2011. • The main objectives of the collaboration are to build capacity to improve specialist services to the rural population. Operation International, an NGO in New York - USA, and the UK since 2013. • HFH has been identified and used as a site for medical and surgical Radboud University - Nijmegen, the Netherlands. CHAG
  • 5. Goals • To gain valuable industry knowledge and experience – nurses unique role is to promote quality health care and improve clinical outcomes, yet ensuring minimal cost of care. • To develop interpersonal skills – nurses may spend much of their time interacting with patients in sensitive circumstances, such as illness and grief. • To become a better patient advocate – nurses are constantly mediating conversations between patients and physicians about treatment plans, helping patients understand medical condition and treatment regimen. • To improve technological skills – it is imperative to stay current on newer technological advancements in the health care sector and to integrate them into practice. • To build professional network – as nurses progress in their career and
  • 6. Interests • Directly caring for patients – the joy you put on their face, the smile they wear… • Volunteering, community service or charity work • Cooking • Sightseeing • Singing • Reading
  • 8.
  • 9. Medical conditions • Hypertension • Diabetes • Cerebrovascular accident – CVA • Heart disease • Meningitis • Pneumonia • RTI
  • 10. • Nifedipine – calcium channel blocker, MoA unknown, but may inhibit Ca+ influx across cardiac and smooth muscles, decreasing myocardial contractility and oxygen demand. 10-20mg tid for Angina Pectoris, 30- 60mg dly adjusted over 7-14days for hypertention • Hydralazine – vasodilator, MoA unknown, but in response to arteriolar dilation, peripheral resistance and blood pressure falls, HR and myocardial contractility increases 10mg qid up tp 50mg • Lisinopril –ace inhibitor, MoA unknown may result primarily from suppression of the RAAS system, 10mg, effective dosage 20-40mg dly • Isosorbide – antianginal drug , reduces cardiac oxygen demand by decreasing left ventricular end diastolic pressure (preload) 2.5 -2.6
  • 11. Hypertension Also known as high blood pressure (HBP), is a long term medical condition in which the blood pressure in the arteries is persistently elevated, (SBP ≥140 mmHg and DBP ≥90 mmHg). Pre hypertension: SBP: 120-139 mmHg, DBP: 80-89 mmHg Hypertension stage I: SBP: 140-159 mmHg, DBP: 90-99 mmHg Hypertension stage II: SBP: More or equal to 160 mmHg, DBP: More or equal to 100 mmHg Pregnancy induced HTN: because of increased production of hormones and enzymes during pregnancy. Medical management  Diuretics: it helps the kidneys to inhibit the sodium reabsorption in the distal convoluted tubules, ascending limb and loop of Henle (E.g.: chlorothiazide - 0.5 -1g, furosemide - starting dose is 80 mg per day, taken as 40 mg twice each day) Beta blockers: These medications reduces the workload of the heart and blood vessel and causing the heart to beat slowly and with less force (E.g.: Atenolol - 25mg to 50mg, propranolol - 40 mg orally 2 times a day) Alpha blockers: These medications causes the peripheral vasodilation of blood vessels (E.g.: Prazosin - 1 mg orally 2 or 3 times a day) Vasodilators: These medications acting directly on the muscles in the wall of arteries and preventing the muscles from tightening and arteries from narrowing. (E.g.: Nitro-glycerine - 5 mcg/min continuous IV infusion increase 3 – 5min up to 20), Sodium nitro prusside) ACE Inhibitors: This group of medication will reduce the conversion of A-I to A-II and prevents vasoconstriction (Eg: Captopril - 25 mg orally 2 to 3 times a day one hour before meals, Ramipril) Calcium channel blockers: These medicines will block the movement of extra cellular calcium into the cells and causing vasodilation and decreased heart rate (E.g.: Amlodipine - 5 to 10 mg/day, Verapamil)
  • 12. Antidiabetes • Sulfunalurease - stimulate insulin secretion from the beta cells of the pancreas, thus increasing insulin levels. Improve sensitivity to insulin in tissues, lower blood glucose levels • 1st Generation - Chlorpropamide, tolbutamide, tolazamide • 2nd Generation – glimepiride, glipizide, glyburide • Meglitinides – repaglinide similar to sulfunalurease • Biguanides – metformin, Decrease production of glucose, Increase uptake of glucose by tissues • Thiazolidinediones, eg. Actos, Avandia - Decrease insulin resistance • Alpha-glucosidase inhibitors, e.g. acarbose reversibly inhibit the alpha-glucosidase in the small intestine, delayed absorption of glucose • Insulin - Restores the diabetic patient’s ability to: • Metabolize carbohydrates, fats, and proteins • Store glucose in the liver • Convert glycogen to fat stores
  • 13. Antimalarial • Artesunate • Artemether • Lumefantrine - Against erythrocytic (but not other) stages of all four malaria species. MOA: unknown. • Chloroquine - Acts by :concentrating in parasite food vacuoles, preventing the biocrystallization of the hemoglobin breakdown product • Amodiaquine

Editor's Notes

  1. The first electrode is placed on the right, below the collar bone and the other is placed over the apex of the heart, on the left side just below and to the left of the chest muscle. AED – Automated External Defibrillator